U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
164971164971Perifosine + Sunitinib Malate for Patients With Advanced CancersCompletedNo Results AvailableRenal Cancer|GISTDrug: Perifosine|Drug: Sunitinib Malatehttps://ClinicalTrials.gov/show/NCT00399152
164972164972Phase I Trial of Paclitaxel With PerifosineCompletedNo Results AvailableNeoplasmsDrug: Perifosine|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT00399126
164973164973Safety Study of 188Re-PTI-6D2 in Patients With Metastatic MelanomaCompletedNo Results AvailableMetastatic MelanomaDrug: 188Re-PTI-6D2https://ClinicalTrials.gov/show/NCT00399113
164974164974Is it Possible to Treat Cyanide Poisoning With HBO?RecruitingNo Results AvailableCarbon Monoxide Poisoning From Fire AccidentsProcedure: HBO - hyperbaric oxygen treatmenthttps://ClinicalTrials.gov/show/NCT00399100
164975164975Phase I Trial of Docetaxel With PerifosineCompletedNo Results AvailableNeoplasmsDrug: Perifosine|Drug: Docetaxel|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00399087
164976164976Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell AnemiaCompletedNo Results AvailableSickle Cell Anemia|MalariaDrug: sulfadoxine pyrimethaminehttps://ClinicalTrials.gov/show/NCT00399074
164977164977Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye SymptomsCompletedNo Results AvailableDry EyeDrug: Systane, Optive, Restasishttps://ClinicalTrials.gov/show/NCT00399061
164978164978An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)CompletedNo Results AvailableOsteoarthritis, Knee|Osteoarthritis, HipDrug: OROS hydromorphone HCL ; OxyContinhttps://ClinicalTrials.gov/show/NCT00399048
164979164979Cediranib (AZD2171, RECENTINâ„¢) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerActive, not recruitingHas ResultsMetastatic Colorectal CancerDrug: Cediranib|Drug: FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)|Drug: XELOX (Capecitabine and Oxaliplatin)|Drug: Cediranib Placebohttps://ClinicalTrials.gov/show/NCT00399035
164980164980Treatment With Duloxetine for OCD PatientsWithdrawnNo Results AvailableOCDDrug: Duloxetinehttps://ClinicalTrials.gov/show/NCT00399022
164981164981Comparative Study of Circular Stapling InstrumentsTerminatedNo Results AvailableAnastomotic Leak|Rectal CancerDevice: AutoSuture Premium Plus CEEA/Ethicon Proximate ILShttps://ClinicalTrials.gov/show/NCT00399009
164982164982A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected PatientsCompletedNo Results AvailableHIV Infections|TuberculosisDrug: Early versus intermediate versus late initiation of ARThttps://ClinicalTrials.gov/show/NCT00398996
164983164983Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)CompletedHas ResultsAcute Myelogenous LeukemiaDrug: Decitabinehttps://ClinicalTrials.gov/show/NCT00398983
164984164984Utility of Endobronchial Ultrasound in the Investigation of Suspected Lung Cancer.CompletedNo Results AvailableLung CancerDevice: Endobronchial ultrasound miniprobehttps://ClinicalTrials.gov/show/NCT00398970
164985164985An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mgCompletedNo Results AvailableAnalgesiaDrug: OROS® Hydromorphone HCL; OROS® Dilaudid; Dilaudid SR (slow release); Naltrexone (an opioid antagonist).https://ClinicalTrials.gov/show/NCT00398957
164986164986Impact of a Computerized Guidelines on the Management of Hypertension and DiabetesCompletedNo Results AvailableDiabetes Mellitus|HypertensionDevice: Evaluation of the impact of a guideline based computerized decision support system.https://ClinicalTrials.gov/show/NCT00398944
164987164987FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)CompletedNo Results AvailableOsteoporosis, PostmenopausalDrug: MK0217, alendronate sodium / Duration of Treatment : 5 Years|Drug: Comparator : placebo (unspecified) /Duration of Treatment : 5 Yearshttps://ClinicalTrials.gov/show/NCT00398931
164988164988Alcohol Self Administration LaboratoryCompletedHas ResultsAlcoholismDrug: zonisamide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00398918
164989164989Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNo Results AvailableVenous ThromboembolismDrug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Enoxaparinhttps://ClinicalTrials.gov/show/NCT00398905
164990164990The Effects of Lipoic Acid on Glycaemic Control in Type 2 DiabetesRecruitingNo Results AvailableDiabetes Mellitus, Type 2Drug: Lipoic acidhttps://ClinicalTrials.gov/show/NCT00398892
164991164991Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer PatientsCompletedNo Results AvailableColon CancerDrug: Perifosine in combination with capecitabinehttps://ClinicalTrials.gov/show/NCT00398879
164992164992A Study of Hyaluronan for the Treatment of Osteoarthritis in the ThumbCompletedNo Results AvailableOsteoarthritisDrug: Synvisc (Hylan G-F20; hyaluronan injection)|Drug: Bupivicaine (local anesthesia injection)|Drug: Kenalog (triamcinolone; corticosteroid injection)https://ClinicalTrials.gov/show/NCT00398866
164993164993Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesDietary Supplement: chromium picolinate 1000 mcg daily vs placebohttps://ClinicalTrials.gov/show/NCT00398853
164994164994A Study of ARQ 171 in Patients With Advanced Solid TumorsSuspendedNo Results AvailableCancerDrug: ARQ 171https://ClinicalTrials.gov/show/NCT00398840
164995164995A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)CompletedNo Results AvailableAnesthesia|Surgical Procedures, ElectiveDrug: Dexmedetomidine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00398827
164996164996Phase I Study of Perifosine + Sorafenib for Patients With Advanced CancersCompletedNo Results AvailableRenal Cancer|TumorsDrug: Perifosine|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT00398814
164997164997Gastroparesis RegistryCompletedNo Results AvailableGastroparesishttps://ClinicalTrials.gov/show/NCT00398801
164998164998A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back PainCompletedNo Results AvailableLow Back PainDrug: OROS® hydromorphone HCL; Dilaudid CR (controlled release); Dilaudid IR (immediate release) as rescue medicinehttps://ClinicalTrials.gov/show/NCT00398788
164999164999Procalcitonin in Fever of Unknown EtiologyTerminatedNo Results AvailableFeverProcedure: antibiotic discontinuationhttps://ClinicalTrials.gov/show/NCT00398775
165000165000Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)CompletedNo Results AvailableAnemia|NeoplasmsDrug: Epoetin alfahttps://ClinicalTrials.gov/show/NCT00398749

* Görseller ve İçerik tekif hakkına sahip olabilir